Zobrazeno 1 - 10
of 218
pro vyhledávání: '"Jonas Oldgren"'
Autor:
Hans Christian Rosén, Moman A. Mohammad, Tomas Jernberg, Stefan James, Jonas Oldgren, David Erlinge
Publikováno v:
The Lancet Regional Health. Europe, Vol 45, Iss , Pp 101032- (2024)
Summary: Background: Sodium-glucose co-transporter 2 (SGLT2) inhibitors have been shown to reduce rates of heart failure hospitalisations and cardiovascular death in patients with type 2 diabetes and prior cardiovascular disease. We hypothesised that
Externí odkaz:
https://doaj.org/article/5ca3e11fd79747bcb17adb6376f215c6
Autor:
Catrin Henriksson, Anneli Olsson, Kasper Andersen, Gabriel Arefalk, David Erlinge, Robin Hofmann, Wilhelm Ridderstråle, Annika Rutgersson, Jonas Oldgren, Stefan James
Publikováno v:
Contemporary Clinical Trials Communications, Vol 40, Iss , Pp 101307- (2024)
Background: The participation of patients in clinical trials is crucial for the development of healthcare. There are several challenges in the recruitment of trial participants with acute medical conditions. The registry-based randomized DAPA-MI clin
Externí odkaz:
https://doaj.org/article/7014313ae53a48eaa10e2dae61abed31
Autor:
Konstantinos I. Gkarmiris, Johan Lindbäck, John H. Alexander, Christopher B. Granger, Peter Kastner, Renato D. Lopes, André Ziegler, Jonas Oldgren, Agneta Siegbahn, Lars Wallentin, Ziad Hijazi
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 13, Iss 7 (2024)
Background BMP10 (bone morphogenic protein 10) has emerged as a novel biomarker associated with the risk of ischemic stroke and other outcomes in patients with atrial fibrillation (AF). The study aimed to determine if repeated BMP10 measurements impr
Externí odkaz:
https://doaj.org/article/f5d8d57bc63349cabf34043da274ff0f
Autor:
Esben Søndergaard, Esben S. Lauritzen, Katrine M. Lauritsen, Axel Åkerblom, Pirjo Nuutila, Jonas Oldgren, Lars C. Gormsen
Publikováno v:
Metabolism Open, Vol 15, Iss , Pp 100207- (2022)
Aims/hypothesis: SGLT2 inhibition is associated with a reduced risk of cardiac disease that is still largely unexplained. According to one hypothesis, improved myocardial energetics may explain the cardioprotective effects of SGLT2i. However, recent
Externí odkaz:
https://doaj.org/article/f5b873c2069047ec995128c138003396
Autor:
Karl Sjölin, Julia Aulin, Lars Wallentin, Niclas Eriksson, Claes Held, Kim Kultima, Jonas Oldgren, Joachim Burman
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 11, Iss 14 (2022)
Background Atrial fibrillation (AF) is associated with stroke and MRI features of cerebral tissue damage but its impact on levels of serum neurofilament light chain (sNFL), an established biochemical marker of neuroaxonal damage, is unknown. Methods
Externí odkaz:
https://doaj.org/article/a944299cf8b745edbcebf298a884fdfc
Autor:
Linda S. B. Johnson, Jonas Oldgren, Tyler W. Barrett, Candace D. McNaughton, Jorge A. Wong, William F. McIntyre, Clifford L. Freeman, Laura Murphy, Gunnar Engström, Michael Ezekowitz, Stuart J. Connolly, Lizhen Xu, Juliet Nakamya, David Conen, Shrikant I. Bangdiwala, Salim Yusuf, Jeff S. Healey
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 10, Iss 18 (2021)
Background Heart failure (HF) is a common complication to atrial fibrillation (AF), leading to rehospitalization and death. Early identification of patients with AF at risk for HF might improve outcomes. We aimed to derive a score to predict 1‐year
Externí odkaz:
https://doaj.org/article/332df64e8cb04f0f99a12de753c5bfa9
Publikováno v:
Upsala Journal of Medical Sciences, Vol 124, Iss 1, Pp 70-77 (2019)
Background: The aim was to determine the association between atrial fibrillation (AF) and outcome in patients undergoing coronary artery bypass grafting (CABG). Methods: All patients undergoing CABG between January 2010 and June 2013 were identified
Externí odkaz:
https://doaj.org/article/1cd9c267b15a46a79cee563296b060f6
Autor:
Axel Åkerblom, Jonas Oldgren, Aino Latva-Rasku, Lars Johansson, Vera Lisovskaja, Cecilia Karlsson, Jan Oscarsson, Pirjo Nuutila
Publikováno v:
Upsala Journal of Medical Sciences, Vol 124, Iss 1, Pp 59-64 (2019)
Background: Diabetes increases the risk for cardiovascular (CV) events. It has recently been shown that the use of sodium-glucose cotransporter 2 (SGLT2) inhibitors leads to a reduction in CV outcomes in patients with type 2 diabetes mellitus (T2DM),
Externí odkaz:
https://doaj.org/article/f5242096a65f475ebd01493bb1c0cb45
Autor:
Ziad Hijazi, Lars Wallentin, Johan Lindbäck, John H. Alexander, Stuart J. Connolly, John W. Eikelboom, Michael D. Ezekowitz, Christopher B. Granger, Renato D. Lopes, Tymon Pol, Salim Yusuf, Jonas Oldgren, Agneta Siegbahn
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 9, Iss 24 (2020)
Background To explore the pathophysiological features of ischemic stroke in patients with atrial fibrillation (AF), we evaluated the association between 268 plasma proteins and subsequent ischemic stroke in 2 large AF cohorts receiving oral anticoagu
Externí odkaz:
https://doaj.org/article/09faa38f34544078bc872e48e57b7a7c
Autor:
Ludvig Elfwén, Rickard Lagedal, Sten Rubertsson, Stefan James, Jonas Oldgren, Jens Olsson, Jacob Hollenberg, Ulf Jensen, Mattias Ringh, Leif Svensson, Per Nordberg
Publikováno v:
International Journal of Cardiology: Heart & Vasculature, Vol 27, Iss , Pp - (2020)
Background: Immediate coronary angiography with subsequent percutaneous coronary intervention (PCI) has the potential to reduce post-resuscitation myocardial dysfunction in out-of-hospital cardiac arrest (OHCA) patients. The aim of this study was to
Externí odkaz:
https://doaj.org/article/eb6add0a01ec4188ac1f3f7041eced94